CTRI/2021/12/038752尚未招募未知
Minocycline as an adjunctive therapy in patients with bipolar mania: A randomized double blind placebo controlled study
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion criteria for group 1 (Minocycline) and Group 2 (Placebo)
- •1. Male inpatients satisfying the ICD 10-DCR[1993] criteria of Bipolar affective disorder, current episode mania with YMRS score of >20.
- •2.Age group of 18-50 years.
- •3.Drug naive or drug free patients for minimum 2 weeks for mood stabilisers/antipsychotics and 4 weeks for depot antipsychotics.
- •4.Those who give informed consent for participating in the study.
排除标准
- •Exclusion criteria for group 1 (Minocycline) and Group 2 (Placebo)
- •1.Any other major co-morbid psychiatric diagnosis and substance dependence excluding nicotine & caffeine.
- •2.Significant current/ past medical or neurological illness including severe hepatic disease and history of severe head injury .
- •3.Known hypersensitivity to Tab. Minocycline or any of its components.
- •4.Patients who had received ECT in last 6 months.
研究者
相似试验
已完成
2 期
Minocycline as a new treatment for depressioACTRN12612000283875Mental Health Research Institute80
招募中
2 期
Minocycline for the treatment of the acute phase of maniaBipolar disorder.Bipolar disorderIRCT20090117001556N155Tehran University of Medical Sciences50
已完成
2 期
Minocycline in the treatment of schizophreniaschizophrenia.schizophreniaIRCT201202241556N34Tehran University of Medical Sciences50
进行中（未招募）
1 期
Oral Minocycline for GAGeographic Atrophy Associated with Age-Related Macular DegenerationEUCTR2017-000946-24-GBational Eye Institute45
已完成
3 期
Minocycline in the treatment OCDObsessive-compulsive disorder.Obsessive-compulsive disorderIRCT201501031556N70Tehran University of Medical Sciences50